NIH-funded research R01 grant

Autism-Linked Maternal Autoantibodies and Brain-Behavior Outcomes

Official title: Autism-Related Autoantibodies and Immune Dysregulation: Outcomes in Brain and Behavior

Funded at University of California at Davis · NIH-11433976 · Data updated 2026-11-12

This grant explores how certain antibodies from a mother during pregnancy may influence autism-related brain development and behavior in children.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$683,451
NIH project number1R01HD123217-01
Project IDNIH-11433976 on NIH RePORTER

Who could benefit from this research

Could help

Children with autism whose mothers have MAR antibodies during pregnancy and who participate in longitudinal imaging and clinical assessments.

Less likely to help

Some children with autism not related to MAR antibodies may not experience these specific subgroup findings or tailored interventions.

What this research studies

The project builds on the Autism Phenome Project to understand a specific autism subtype called maternal autoantibody-related autism (MAR). It combines neuroimaging data with information about maternal antibodies that target fetal brain proteins to identify distinct brain and behavioral patterns. By studying families over time, researchers aim to connect biological signals with autism features and outcomes. This work could help identify who is most affected by MAR and what to monitor as children grow.

Why it matters

Potential benefit: If successful, the study could improve identification of autism subtypes linked to MAR and guide personalized monitoring and interventions.

How similar studies have gone: Preliminary neuroimaging suggests MAR-related subtypes have distinct brain growth patterns, but comprehensive human data are still emerging.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Lee, Joshua Kirk — University of California at Davis
  • Study coordinator: Lee, Joshua Kirk

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.